Brockbank remedy for patent worries.

Lloyd's-based Brockbank Syndicate Management has launched a new
intellectual property patent infringement product for pharmaceutical
companies and medical device manufacturers.

This product protects against damages attributable to claims for wilful
infringement, where a pharmaceutical company may have infringed another's
patent, by conducting tests on its product before the patent has

Until now, this is an aspect of cover which many insurers have shied away
from, according to Ron Reshefsky,

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected].

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: